Presentation TCT 2015 We Need More Data: STABLE and PREVENT Presenter: Seung-Jung Park October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Slow Down, Excess Bleeding, and No Mortality Benefit? Primum Non Nocere and Save Costs! Presenter: Tullio Palmerini October 11, 2015 More slides + Presentation TCT 2015 Advanced CLI BTK Intervention: Two Cases From a Master Level Operator Presenter: Andrej Schmidt October 11, 2015 Presentation TCT 2015 Pharmacology in the Lab: Heparin or Bivalirudin? Presenter: Ehtisham Mahmud October 11, 2015 We Recommend
Presentation TCT 2015 Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Slow Down, Excess Bleeding, and No Mortality Benefit? Primum Non Nocere and Save Costs! Presenter: Tullio Palmerini October 11, 2015
Presentation TCT 2015 Advanced CLI BTK Intervention: Two Cases From a Master Level Operator Presenter: Andrej Schmidt October 11, 2015
Presentation TCT 2015 Pharmacology in the Lab: Heparin or Bivalirudin? Presenter: Ehtisham Mahmud October 11, 2015